PSILOBRAIN

Class [005]
Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of neurological disorders, namely brain injury, spinal cord injury, and seizure disorders; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; pharmaceutical preparations, namely neurological and psychological pharmaceutical preparations for the treatment of eating disorders and addictions; pharmaceutical preparations, namely drug delivery agents in the form of capsules, powders, edible wafers, lozenges, tablets, and transdermal patches that facilitate the delivery of hallucinogenic formulated products; pharmaceutical preparations, namely baeocystine, bufotenine, ergolines, N,N-demethyltryptamine, phenethylamines, psilocybin, and psilocin; pharmaceutical preparations, namely hallucinogenic formulated products, namely psychotropics; mushroom-based nutrition products and consumables, namely dietary and nutritional supplements consisting of mushroom-derived psychotropics; mushroom-based nutrition products and consumables, namely dietary and nutritional supplements consisting of mushroom-derived psychotropics and cannabinoid extracts; mushroom-based nutrition products and consumables, namely dietary and nutritional supplements containing mushroom extracts, namely oral sprays, tinctures, gummies, and recovery shots for medicinal purposes and recreational purposes; mushroom-based nutrition products and consumables, namely dietary and nutritional supplements containing mushroom extracts and cannabinoid extracts, namely oral sprays, tinctures, gummies, and recovery shots for medicinal purposes and recreational purposes; mushroom-based nutrition products and consumables consisting of functional mushroom extracts and herbal extracts, namely lion's mane, ashwagandha, and amanita muscaria extracts; mushroom-based nutrition products and consumables consisting of functional mushroom extracts, herbal extracts, and cannabinoids, namely lion's mane, ashwagandha, and amanita muscaria extracts combined with cannabidiol; mushroom-based nutrition products and consumables, namely biochemical preparations containing psilocybin mushrooms in powdered form for the treatment of mental health disorders and for recreational purposes.